Stock Analysis, Dividends, Split History
ENDV / Endonovo Therapeutics, Inc. financial ratios include Market Cap,
Enterprise Value, Book Value, Quick Ratio, Current Ratio,
NCAV, EBITDA, Profit Margin, Operating Margin,
Return on Invested Capital (ROIC),
Return on Assets (ROA), Return on Equity (ROE),
Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.
|Market Cap ($M)||21.89|
|Enterprise Value ($M)||29.32|
|Book Value ($M)||-9.12|
|Book Value / Share||-0.02|
|Price / Book||-2.40|
|NCAV / Share||-0.04|
|Price / NCAV||-1.65|
|Balance Sheet (mrq) ($M)|
|Identifiers and Descriptors|
Central Index Key (CIK)||1528172|
Stock splits are used by Endonovo Therapeutics, Inc. to keep share prices within reasonable numbers to encourage
investment. If the share price of a security gets too high, a company can perform a stock split
by issuing all shareholders an extra share, thereby halving the price of an individual share.
If the share price gets too low, companies can do reverse splits. This is common when
share prices drop below $1.00 and company's become in danger of being delisted. However, because
of the cost, stock splits are not a normal business occurrence.